| Diabetes Treatment and Management | Lifetime | 280 | FR 5 | 98.88 |
| Heart Failure Treatment and Management | Lifetime | 276 | FR 7 | 98.96 |
| Cardiovascular Function and Risk Factors | Lifetime | 701 | FR 15 | 98.80 |
| Hormonal Regulation and Hypertension | Lifetime | 427 | FR 20 | 98.00 |
| Pancreatic function and diabetes | Lifetime | 674 | FR 23 | 98.16 |
| Potassium and Related Disorders | Lifetime | 89 | FR 2 | 97.97 |
| Blood Pressure and Hypertension Studies | Lifetime | 986 | FR 27 | 97.44 |
| GDF15 and Related Biomarkers | Lifetime | 97 | FR 2 | 93.60 |
| Electrolyte and hormonal disorders | Lifetime | 758 | FR 24 | 94.54 |
| Heart rate and cardiovascular health | Lifetime | 796 | FR 29 | 65.76 |
| Pancreatic function and diabetes | 2021-2025 | 5 | FR 1 | 99.82 |
| Diabetes Treatment and Management | 2021-2025 | 16 | FR 1 | 99.85 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 34 | FR 1 | 99.76 |
| Heart Failure Treatment and Management | 2021-2025 | 22 | FR 1 | 99.83 |
| Hormonal Regulation and Hypertension | 2021-2025 | 10 | FR 1 | 99.49 |
| Potassium and Related Disorders | 2021-2025 | 7 | FR 1 | 99.35 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 34 | FR 1 | 98.91 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 129 | FR 2 | 97.44 |
| Diabetes Management and Research | 2021-2025 | 220 | FR 2 | 96.98 |
| Electrolyte and hormonal disorders | 2021-2025 | 39 | FR 3 | 95.32 |
| GDF15 and Related Biomarkers | 2021-2025 | 23 | FR 4 | 92.04 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 38 | FR 2 | 95.26 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 403 | FR 23 | 92.41 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 693 | FR 35 | 92.92 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 153 | FR 2 | 86.15 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 551 | FR 14 | 86.64 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 51 | FR 3 | 86.46 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 722 | FR 16 | 86.17 |
| Statistical Methods in Clinical Trials | 2021-2025 | 413 | FR 10 | 80.91 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 367 | FR 9 | 79.86 |
| Adenosine and Purinergic Signaling | 2021-2025 | 408 | FR 15 | 75.53 |
| Ion Transport and Channel Regulation | 2021-2025 | 231 | FR 13 | 76.31 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 427 | FR 4 | 75.18 |
